US Stock MarketDetailed Quotes

ELTX Elicio Therapeutics

Watchlist
  • 5.070
  • +0.080+1.60%
Close Dec 13 16:00 ET
  • 5.070
  • 0.0000.00%
Post 20:01 ET
54.71MMarket Cap-1.17P/E (TTM)

Elicio Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-3.96%10.34M
40.47%10.92M
31.21%10.24M
50.61%35.75M
57.56%9.39M
86.67%10.77M
24.79%7.78M
7.81M
-6.84%23.73M
5.96M
Selling and administrative expenses
-10.58%3.14M
-3.14%2.74M
15.55%2.68M
111.30%11.9M
93.60%3.24M
197.96%3.51M
137.87%2.83M
--2.32M
-25.36%5.63M
--1.67M
-General and administrative expense
-10.58%3.14M
-3.14%2.74M
15.55%2.68M
111.30%11.9M
93.60%3.24M
197.96%3.51M
137.87%2.83M
--2.32M
-25.36%5.63M
--1.67M
Research and development costs
-0.77%7.21M
65.45%8.18M
37.84%7.56M
31.74%23.85M
43.52%6.16M
58.15%7.26M
-1.92%4.94M
--5.48M
0.95%18.1M
--4.29M
Operating profit
3.96%-10.34M
-40.47%-10.92M
-31.21%-10.24M
-50.61%-35.75M
-57.56%-9.39M
-86.67%-10.77M
-24.79%-7.78M
-7.81M
6.84%-23.73M
-5.96M
Net non-operating interest income expense
-1,273.88%-2.88M
113.04%88K
-39.76%-464K
80.58%-686K
297.30%73K
122.94%245K
36.74%-675K
-332K
-304.56%-3.53M
-37K
Non-operating interest income
-24.80%185K
251.28%137K
1,400.00%150K
473.85%373K
36.36%75K
2,360.00%246K
--39K
--10K
1,816.27%65K
--55K
Non-operating interest expense
13,600.00%137K
-93.14%49K
-89.47%36K
-70.56%1.06M
-97.83%2K
-99.91%1K
-33.08%714K
--342K
310.41%3.6M
--92K
Total other finance cost
--2.92M
----
--578K
----
----
----
----
----
----
----
Other net income (expense)
-4,156.06%-5.62M
303.92%3.61M
-1,138.89%-1.12M
231.07%1.24M
156.66%370K
63.33%-132K
893K
108K
-1,680.52%-943K
-653K
Gain on sale of security
-20,707.41%-5.62M
1,148.10%3.61M
-1,141.67%-1.13M
166.77%631K
140.06%264K
92.50%-27K
--289K
--108K
-1,684.30%-945K
---659K
Special income (charges)
--0
--0
--3K
30,150.00%605K
1,666.67%106K
---105K
--604K
--0
--2K
--6K
-Less:Other special charges
----
----
----
-30,150.00%-605K
---1K
----
---604K
----
---2K
----
-Gain on sale of property,plant,equipment
--0
--0
--3K
----
----
---105K
--0
--0
----
----
Income before tax
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.07%-10.66M
-3.56%-7.56M
-8.03M
-6.85%-28.21M
-6.65M
Income tax
Net income
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.07%-10.66M
-3.56%-7.56M
-8.03M
-6.85%-28.21M
-6.65M
Net income continuous Operations
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.07%-10.66M
-3.56%-7.56M
---8.03M
-6.85%-28.21M
---6.65M
Minority interest income
Net income attributable to the parent company
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.07%-10.66M
-3.56%-7.56M
-8.03M
-6.85%-28.21M
-6.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-76.75%-18.84M
4.37%-7.23M
-47.30%-11.83M
-24.77%-35.2M
-34.55%-8.95M
-48.07%-10.66M
-3.56%-7.56M
-8.03M
-6.85%-28.21M
-6.65M
Basic earnings per share
-9.45%-1.39
75.48%-0.64
-25.07%-1.15
-158.18%-6.96
-46.60%-0.9318
-84.62%-1.27
-274.17%-2.61
-0.9195
-6.85%-2.6958
-0.6356
Diluted earnings per share
-9.45%-1.39
75.48%-0.64
-25.07%-1.15
-158.18%-6.96
-46.60%-0.9318
-84.62%-1.27
-274.17%-2.61
-0.9195
-6.85%-2.6958
-0.6356
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -3.96%10.34M40.47%10.92M31.21%10.24M50.61%35.75M57.56%9.39M86.67%10.77M24.79%7.78M7.81M-6.84%23.73M5.96M
Selling and administrative expenses -10.58%3.14M-3.14%2.74M15.55%2.68M111.30%11.9M93.60%3.24M197.96%3.51M137.87%2.83M--2.32M-25.36%5.63M--1.67M
-General and administrative expense -10.58%3.14M-3.14%2.74M15.55%2.68M111.30%11.9M93.60%3.24M197.96%3.51M137.87%2.83M--2.32M-25.36%5.63M--1.67M
Research and development costs -0.77%7.21M65.45%8.18M37.84%7.56M31.74%23.85M43.52%6.16M58.15%7.26M-1.92%4.94M--5.48M0.95%18.1M--4.29M
Operating profit 3.96%-10.34M-40.47%-10.92M-31.21%-10.24M-50.61%-35.75M-57.56%-9.39M-86.67%-10.77M-24.79%-7.78M-7.81M6.84%-23.73M-5.96M
Net non-operating interest income expense -1,273.88%-2.88M113.04%88K-39.76%-464K80.58%-686K297.30%73K122.94%245K36.74%-675K-332K-304.56%-3.53M-37K
Non-operating interest income -24.80%185K251.28%137K1,400.00%150K473.85%373K36.36%75K2,360.00%246K--39K--10K1,816.27%65K--55K
Non-operating interest expense 13,600.00%137K-93.14%49K-89.47%36K-70.56%1.06M-97.83%2K-99.91%1K-33.08%714K--342K310.41%3.6M--92K
Total other finance cost --2.92M------578K----------------------------
Other net income (expense) -4,156.06%-5.62M303.92%3.61M-1,138.89%-1.12M231.07%1.24M156.66%370K63.33%-132K893K108K-1,680.52%-943K-653K
Gain on sale of security -20,707.41%-5.62M1,148.10%3.61M-1,141.67%-1.13M166.77%631K140.06%264K92.50%-27K--289K--108K-1,684.30%-945K---659K
Special income (charges) --0--0--3K30,150.00%605K1,666.67%106K---105K--604K--0--2K--6K
-Less:Other special charges -------------30,150.00%-605K---1K-------604K-------2K----
-Gain on sale of property,plant,equipment --0--0--3K-----------105K--0--0--------
Income before tax -76.75%-18.84M4.37%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.07%-10.66M-3.56%-7.56M-8.03M-6.85%-28.21M-6.65M
Income tax
Net income -76.75%-18.84M4.37%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.07%-10.66M-3.56%-7.56M-8.03M-6.85%-28.21M-6.65M
Net income continuous Operations -76.75%-18.84M4.37%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.07%-10.66M-3.56%-7.56M---8.03M-6.85%-28.21M---6.65M
Minority interest income
Net income attributable to the parent company -76.75%-18.84M4.37%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.07%-10.66M-3.56%-7.56M-8.03M-6.85%-28.21M-6.65M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -76.75%-18.84M4.37%-7.23M-47.30%-11.83M-24.77%-35.2M-34.55%-8.95M-48.07%-10.66M-3.56%-7.56M-8.03M-6.85%-28.21M-6.65M
Basic earnings per share -9.45%-1.3975.48%-0.64-25.07%-1.15-158.18%-6.96-46.60%-0.9318-84.62%-1.27-274.17%-2.61-0.9195-6.85%-2.6958-0.6356
Diluted earnings per share -9.45%-1.3975.48%-0.64-25.07%-1.15-158.18%-6.96-46.60%-0.9318-84.62%-1.27-274.17%-2.61-0.9195-6.85%-2.6958-0.6356
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data